The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections
Authors:
- Arnaud John Kombe KombeArnaud John Kombe Kombe
- Leila FotoohabadiLFLeila Fotoohabadi
- Ravikanth NanduriRavikanth Nanduri
- Yulia GerasimovaYGYulia Gerasimova
- Maria DaskouMDMaria Daskou
- Chandrima GainCGChandrima Gain
- Eashan SharmaESEashan Sharma
- Michael WongMWMichael Wong
- Theodoros KelesidisTKTheodoros Kelesidis
Open Access
- 27 June 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7042
Abstract
Respiratory viruses constitute a significant cause of illness and death worldwide. Respiratory virus-associated injuries include oxidative stress, ferroptosis, inflammation, pyroptosis, apoptosis, fibrosis, autoimmunity, and vascular injury. Several studies have demonstrated the involvement of the nuclear factor erythroid 2-related factor 2 (Nrf2) in the pathophysiology of viral infection and associated complications. It has thus emerged as a pivotal player in cellular defense mechanisms against such damage. Here, we discuss the impact of Nrf2 activation on airway injuries induced by respiratory viruses, including viruses, coronaviruses, rhinoviruses, and respiratory syncytial viruses. The inhibition or deregulation of Nrf2 pathway activation induces airway tissue damage in the presence of viral respiratory infections. In contrast, Nrf2 pathway activation demonstrates protection against tissue and organ injuries. Clinical trials involving Nrf2 agonists are needed to define the effect of Nrf2 therapeutics on airway tissues and organs damaged by viral respiratory infections.Keywords
Funding Information
- National Institutes of Health (R01AG059501)
This publication has 262 references indexed in Scilit:
- Pyrogallol protects against influenza A virus‐triggered lethal lung injury by activating the Nrf2–PPAR‐γ–HO‐1 signaling axisMedcomm, 2024
- COVID‐19: A trigger of autoimmune diseasesCell Biology International, 2023
- Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2Reviews in Medical Virology, 2021
- Antiinflammatory phytochemicals against virus‐induced hyperinflammatory responses: Scope, rationale, application, and limitationsPhytotherapy Research, 2021
- Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trialsPhytotherapy Research, 2021
- Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicalsBioFactors, 2021
- Fatal Lymphocytic Cardiac Damage in Coronavirus Disease 2019 (COVID-19): Autopsy Reveals a Ferroptosis SignatureESC Heart Failure, 2020
- Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane2012
- Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's diseaseGlia, 2009
- Viruses in community‐acquired pneumonia in children aged less than 3 years old: High rate of viral coinfectionJournal of Medical Virology, 2008